Trial Profile
A Phase 2, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Televancin (TD-6424) for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jan 2019
Price :
$35
*
At a glance
- Drugs Telavancin (Primary) ; Cloxacillin; Nafcillin; Oxacillin; Vancomycin
- Indications Bacteraemia; Staphylococcal infections
- Focus Therapeutic Use
- Acronyms ASSURE
- Sponsors Theravance Biopharma
- 26 Mar 2011 New trial record